Skip to main content
Top
Published in: Radiation Oncology 1/2015

Open Access 01-12-2015 | Research

A randomized study of the effect of patient positioning on setup reproducibility and dose distribution to organs at risk in radiotherapy of rectal cancer patients

Authors: Trude C. Frøseth, Trond Strickert, Kjersti S. Solli, Øyvind Salvesen, Gunilla Frykholm, Randi J. Reidunsdatter

Published in: Radiation Oncology | Issue 1/2015

Login to get access

Abstract

Background

The patient positioning in pelvic radiotherapy (RT) should be decided based on both reproducibility and on which position that yields the lowest radiation dose to the organs at risk (OAR), and thereby less side effects to patients. The present randomized study aimed to evaluate the influence of patient positioning on setup reproducibility and dose distribution to OAR in rectal cancer patients.

Methods

Ninety-one patients were randomized into receiving RT in either supine or prone position. The recruitment period was from 2005 to 2008. Position deviations were derived from electronic portal image registrations, and setup errors were defined as deviations between the expected and the actual position of bony landmarks. Setup deviations were expressed into three table shift values (∆x, ∆y, ∆z) from which the deviation vector \( \left|\overrightarrow{v}\right| \) were calculated. The estimated lengths of \( \left|\overrightarrow{v}\right| \) defined the main outcome and were compared between prone and supine positions using linear mixed model statistics. The mean volume of each 5 Gy increments between 5 and 45 Gy was calculated for the small bowel and the total bowel, and the dose volumes were compared between prone and supine position.

Results and conclusion

Data from 83 patients was evaluable. The mean \( \left|\overrightarrow{v}\right| \) was 5.8 mm in supine position and 7.1 mm in prone position (p = 0.024), hence the reproducibility was significantly superior in supine position. However, the difference was marginal and may have borderline clinical importance. The irradiated volumes of the small bowel and the total bowel were largest in the supine position for all dose levels, but none of those were significantly different. The patient positioning in RT of rectal cancer patients may therefore be decided based on other factors such as the most comfortable position for the patients.
Literature
1.
go back to reference Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRefPubMed Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRefPubMed
3.
go back to reference Sebag-Monefiore D, Bujko K, Valentini V. Rectal cancer multidisciplinary management: evidences and future landscape. Radiother Oncol. 2009;92:145–7.CrossRef Sebag-Monefiore D, Bujko K, Valentini V. Rectal cancer multidisciplinary management: evidences and future landscape. Radiother Oncol. 2009;92:145–7.CrossRef
4.
go back to reference Brændengen M, Tveit KM, Berglund Å, Birkemeyer E, Frykholm G, Påhlman L, et al. Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer. J Clin Oncol. 2008;26(22):3687–94.CrossRefPubMed Brændengen M, Tveit KM, Berglund Å, Birkemeyer E, Frykholm G, Påhlman L, et al. Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer. J Clin Oncol. 2008;26(22):3687–94.CrossRefPubMed
5.
go back to reference Brændengen M, Tveit KM, Hjermstad MJ, Johansson H, Berglund Å, Brandberg Y, et al. Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long term results from a phase III study. Eur J Cancer. 2012;48:813–9.CrossRefPubMed Brændengen M, Tveit KM, Hjermstad MJ, Johansson H, Berglund Å, Brandberg Y, et al. Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long term results from a phase III study. Eur J Cancer. 2012;48:813–9.CrossRefPubMed
6.
go back to reference Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, et al. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2010;76(4):1005–11.CrossRefPubMed Bruheim K, Guren MG, Skovlund E, Hjermstad MJ, Dahl O, Frykholm G, et al. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2010;76(4):1005–11.CrossRefPubMed
7.
go back to reference Nijkamp J, de Jong R, Sonke JJ, van Vliet C, Marijnen C. Target volume shape variation during irradiation of rectal cancer patients in supine position: Comparison with prone position. Radiother Oncol. 2009;93:285–92.CrossRefPubMed Nijkamp J, de Jong R, Sonke JJ, van Vliet C, Marijnen C. Target volume shape variation during irradiation of rectal cancer patients in supine position: Comparison with prone position. Radiother Oncol. 2009;93:285–92.CrossRefPubMed
8.
go back to reference Wiesendanger-Wittmer EM, Sijtsema NM, Mujis CT, Beukema JC. Systematic review of the role of a belly board device in radiotherapy delivery in patients with pelvic malignancies. Radiother Oncol. 2012;102(3):325–34.CrossRefPubMed Wiesendanger-Wittmer EM, Sijtsema NM, Mujis CT, Beukema JC. Systematic review of the role of a belly board device in radiotherapy delivery in patients with pelvic malignancies. Radiother Oncol. 2012;102(3):325–34.CrossRefPubMed
9.
go back to reference Lin LL, Hertan L, Rengan R, Teo BKK. Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. Int J Radiat Oncol Biol Phys. 2012;83:670–5.CrossRefPubMed Lin LL, Hertan L, Rengan R, Teo BKK. Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. Int J Radiat Oncol Biol Phys. 2012;83:670–5.CrossRefPubMed
10.
go back to reference Yoon WS, Yang DS, Lee JA, Park YJ, Kim CY. Risk factors related to interfractional variation in whole pelvic irradiation for locally advanced pelvic malignancies. Strahlenther Onkol. 2012;188:395–403.CrossRefPubMed Yoon WS, Yang DS, Lee JA, Park YJ, Kim CY. Risk factors related to interfractional variation in whole pelvic irradiation for locally advanced pelvic malignancies. Strahlenther Onkol. 2012;188:395–403.CrossRefPubMed
11.
go back to reference Weber DC, Nouet P, Rouzaud M, Miralbell R. Patient positioning in prostate radiotherapy: is prone better than supine? Int J Radiat Oncol Biol Phys. 2000;47:365–71.CrossRefPubMed Weber DC, Nouet P, Rouzaud M, Miralbell R. Patient positioning in prostate radiotherapy: is prone better than supine? Int J Radiat Oncol Biol Phys. 2000;47:365–71.CrossRefPubMed
12.
go back to reference Bayley AJ, Catton CN, Haycocks T, Kelly V, Alasti H, Bristow R, et al. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol. 2004;70:37–44.CrossRefPubMed Bayley AJ, Catton CN, Haycocks T, Kelly V, Alasti H, Bristow R, et al. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer. Radiother Oncol. 2004;70:37–44.CrossRefPubMed
13.
go back to reference Drzymala M, Hawkins MA, Henrys AJ, Bedford J, Norman A, Tait DM. The effect of treatment position, prone or supine, on dose-volume histograms for pelvic radiotherapy in patients with rectal cancer. Br J Radiol. 2009;82:321–7.CrossRefPubMed Drzymala M, Hawkins MA, Henrys AJ, Bedford J, Norman A, Tait DM. The effect of treatment position, prone or supine, on dose-volume histograms for pelvic radiotherapy in patients with rectal cancer. Br J Radiol. 2009;82:321–7.CrossRefPubMed
14.
go back to reference Siddiqui F, Shi C, Papanikolaou N, Fuss M. Image-guidance protocol comparison: Supine and prone set-up accuracy for pelvic radiation therapy. Acta Oncol. 2008;47:1344–50.CrossRefPubMed Siddiqui F, Shi C, Papanikolaou N, Fuss M. Image-guidance protocol comparison: Supine and prone set-up accuracy for pelvic radiation therapy. Acta Oncol. 2008;47:1344–50.CrossRefPubMed
15.
go back to reference Banerjee R, Chakraborty S, Nygren I, Sinha R. Small bowel dose parameters predicting grade ≥3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space evrsus small bowel loop contouring techniques. Int J Radiat Oncol Biol Phys. 2012;85(5):1225–31.CrossRefPubMed Banerjee R, Chakraborty S, Nygren I, Sinha R. Small bowel dose parameters predicting grade ≥3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space evrsus small bowel loop contouring techniques. Int J Radiat Oncol Biol Phys. 2012;85(5):1225–31.CrossRefPubMed
16.
go back to reference Robertson JM, Lockman D, Yan D, Wallace M. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2008;70(2):413–8.CrossRefPubMed Robertson JM, Lockman D, Yan D, Wallace M. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2008;70(2):413–8.CrossRefPubMed
17.
go back to reference Tho LM, Glegg M, Paterson J, Yap C, MacLeod A, McCabe M, et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys. 2006;66(2):505–13.CrossRefPubMed Tho LM, Glegg M, Paterson J, Yap C, MacLeod A, McCabe M, et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys. 2006;66(2):505–13.CrossRefPubMed
18.
go back to reference Pinkawa M, Gagel B, Demirel C, Schmachtenberg A, Asadpour B, Eble MJ. Dose-volume histogram evaluation of prone and supine patient position in external beam radiotherapy for cervical and endometrial cancer. Radiother Oncol. 2003;69:99–105.CrossRefPubMed Pinkawa M, Gagel B, Demirel C, Schmachtenberg A, Asadpour B, Eble MJ. Dose-volume histogram evaluation of prone and supine patient position in external beam radiotherapy for cervical and endometrial cancer. Radiother Oncol. 2003;69:99–105.CrossRefPubMed
19.
go back to reference Kavanagh BD, Pan CC, Dawson LA, Das SK, Li A, Ten Haken RK, et al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010;76(3):101–7.CrossRef Kavanagh BD, Pan CC, Dawson LA, Das SK, Li A, Ten Haken RK, et al. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010;76(3):101–7.CrossRef
20.
go back to reference Gunnlaugsson A, Kjellèn E, Nilsson P, Bendahl PO, Willner J, Johnsson A. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol. 2007;46(7):937–44.CrossRefPubMed Gunnlaugsson A, Kjellèn E, Nilsson P, Bendahl PO, Willner J, Johnsson A. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol. 2007;46(7):937–44.CrossRefPubMed
21.
go back to reference Baglan KL, Frazier RC, Yan D, Huang RR, Martinez AA, Robertson JM. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2002;52(1):176–83.CrossRefPubMed Baglan KL, Frazier RC, Yan D, Huang RR, Martinez AA, Robertson JM. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2002;52(1):176–83.CrossRefPubMed
22.
go back to reference Chen RC, Mamon HJ, Ancukiewicz M, Killoran JH, Crowley EM, Blaszkowsky LS, et al. Dose-volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2012;83(4):513–7.CrossRef Chen RC, Mamon HJ, Ancukiewicz M, Killoran JH, Crowley EM, Blaszkowsky LS, et al. Dose-volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2012;83(4):513–7.CrossRef
23.
go back to reference el-Gayed AA, Vijlbrief R, Bartelink H, Lebesque JV. Time trend of patient setup deviations during pelvic irradiation using electronic portal imaging. Radiother Oncol. 1993;26(2):162–71.CrossRefPubMed el-Gayed AA, Vijlbrief R, Bartelink H, Lebesque JV. Time trend of patient setup deviations during pelvic irradiation using electronic portal imaging. Radiother Oncol. 1993;26(2):162–71.CrossRefPubMed
24.
go back to reference Koelbl O, Richter S, Flentje M. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model. Int J Radiat Oncol Biol Phys. 1999;45(5):1193–8.CrossRefPubMed Koelbl O, Richter S, Flentje M. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model. Int J Radiat Oncol Biol Phys. 1999;45(5):1193–8.CrossRefPubMed
25.
go back to reference Bijl HP, Luijk P, Coppes RP, Schippers JM, Konings AWT, Kogel A. Unexpected changes of rat cervical spinal cord tolerance caused by inhomogenous dose distributions. Int J Radiat Oncol Biol Phys. 2003;57(1):274–81.CrossRefPubMed Bijl HP, Luijk P, Coppes RP, Schippers JM, Konings AWT, Kogel A. Unexpected changes of rat cervical spinal cord tolerance caused by inhomogenous dose distributions. Int J Radiat Oncol Biol Phys. 2003;57(1):274–81.CrossRefPubMed
26.
go back to reference Richetti A, Fogliata A, Clivio A, Nicolini G, Pesce G, Salati E, et al. Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience. Radiat Oncol. 2010;5:14.PubMedCentralCrossRefPubMed Richetti A, Fogliata A, Clivio A, Nicolini G, Pesce G, Salati E, et al. Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience. Radiat Oncol. 2010;5:14.PubMedCentralCrossRefPubMed
27.
go back to reference Gwynne S, Mukherjee S, Webster R, Spezi E, Staffurth J, Coles B, et al. Imaging for target volume delineation in rectal cancer radiotherapy — a systematic review. Clin Oncol. 2012;24:52–63.CrossRef Gwynne S, Mukherjee S, Webster R, Spezi E, Staffurth J, Coles B, et al. Imaging for target volume delineation in rectal cancer radiotherapy — a systematic review. Clin Oncol. 2012;24:52–63.CrossRef
Metadata
Title
A randomized study of the effect of patient positioning on setup reproducibility and dose distribution to organs at risk in radiotherapy of rectal cancer patients
Authors
Trude C. Frøseth
Trond Strickert
Kjersti S. Solli
Øyvind Salvesen
Gunilla Frykholm
Randi J. Reidunsdatter
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2015
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-015-0524-3

Other articles of this Issue 1/2015

Radiation Oncology 1/2015 Go to the issue